| # | Title | Journal | Year | Citations |
|---|
| 1 | Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells | Nature Medicine | 1998 | 2,689 |
| 2 | Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway | Nature | 2017 | 1,194 |
| 3 | Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I | Journal of the European Academy of Dermatology and Venereology | 2018 | 727 |
| 4 | Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II | Journal of the European Academy of Dermatology and Venereology | 2018 | 519 |
| 5 | Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab | Clinical Cancer Research | 2016 | 480 |
| 6 | Defining early mycosis fungoides | Journal of the American Academy of Dermatology | 2005 | 453 |
| 7 | Patterns of onset and resolution of immune‐related adverse events of special interest with ipilimumab | Cancer | 2013 | 394 |
| 8 | European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017 | European Journal of Cancer | 2017 | 363 |
| 9 | sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance | Nature | 2016 | 290 |
| 10 | Diagnostic delay in hidradenitis suppurativa is a global problem | British Journal of Dermatology | 2015 | 261 |
| 11 | Induction of Genes Mediating Interferon-dependent Extracellular Trap Formation during Neutrophil Differentiation | Journal of Biological Chemistry | 2004 | 247 |
| 12 | Absence of T-regulatory cell expression and function in atopic dermatitis skin | Journal of Allergy and Clinical Immunology | 2006 | 233 |
| 13 | Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases | Journal of Immunology | 2002 | 225 |
| 14 | Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T‐cell lymphoma | Cancer | 2003 | 211 |
| 15 | Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial | Lancet Oncology, The | 2015 | 206 |
| 16 | Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study | Annals of Oncology | 2017 | 201 |
| 17 | Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy | Cancer Cell | 2016 | 198 |
| 18 | Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults | Journal of Allergy and Clinical Immunology | 2006 | 190 |
| 19 | Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain) | Blood | 1996 | 166 |
| 20 | T Cells and T Cell-Derived Cytokines as Pathogenic Factors in the Nonallergic Form of Atopic Dermatitis | Journal of Investigative Dermatology | 1999 | 165 |
| 21 | Intratumoral Injection of DNA Encoding Human Interleukin 12 into Patients with Metastatic Melanoma: Clinical Efficacy | Human Gene Therapy | 2005 | 137 |
| 22 | Keratin 1 maintains skin integrity and participates in an inflammatory network in skin via interleukin-18 | Journal of Cell Science | 2012 | 134 |
| 23 | EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation | Cancer Cell | 2018 | 123 |
| 24 | Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis | Annals of Oncology | 2008 | 122 |
| 25 | Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice | Nature Communications | 2019 | 114 |
| 26 | Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy | British Journal of Cancer | 2017 | 112 |
| 27 | Direct intralymphatic injection of peptide vaccines enhances immunogenicity | European Journal of Immunology | 2005 | 105 |
| 28 | Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer | Nature Chemical Biology | 2018 | 105 |
| 29 | Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study | British Journal of Dermatology | 2020 | 104 |
| 30 | The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients | British Journal of Cancer | 1992 | 99 |
| 31 | Liver Allograft Failure After Nivolumab Treatment—A Case Report With Systematic Literature Research | Transplantation Direct | 2018 | 98 |
| 32 | Expression of MxA protein in inflammatory dermatoses. | Journal of Histochemistry and Cytochemistry | 1995 | 97 |
| 33 | Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid | Archives of Dermatological Research | 1996 | 85 |
| 34 | Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma | Cancer Cell | 2021 | 83 |
| 35 | Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism | Nature Cancer | 2021 | 83 |
| 36 | Oral Hairy Leukoplakia in a HIV-Negative Renal Transplant Patient: A Marker for Immunosuppression? | Dermatology | 1988 | 80 |
| 37 | Drug-Induced Lichen Planus | Clinics in Dermatology | 1998 | 77 |
| 38 | The state of melanoma: challenges and opportunities | Pigment Cell and Melanoma Research | 2016 | 77 |
| 39 | Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma | Genome Biology | 2015 | 76 |
| 40 | Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome | European Journal of Immunology | 2003 | 73 |
| 41 | Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance | Oncotarget | 2016 | 73 |
| 42 | Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant | Cell Reports | 2019 | 73 |
| 43 | Prevalence, predictors and comorbidity of dry skin in the general population | Journal of the European Academy of Dermatology and Venereology | 2019 | 72 |
| 44 | The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support | Cancer Cell | 2021 | 71 |
| 45 | Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study | Archives of Dermatological Research | 1996 | 70 |
| 46 | Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition | Clinical Cancer Research | 2020 | 70 |
| 47 | Neutrophilic Epitheliotropism Is a Histopathological Clue to Neutrophilic Urticarial Dermatosis | American Journal of Dermatopathology | 2016 | 65 |
| 48 | A fresh morphological and functional at dermal dendritic cells | Journal of Cutaneous Pathology | 1995 | 64 |
| 49 | Suppression of UV-lnduced Erythema by Topical Treatment with Melatonin (N-Acetyl-5-Methoxytryptamine) | Dermatology | 1997 | 63 |
| 50 | Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure | EMBO Molecular Medicine | 2017 | 63 |
